Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is December - November.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Market Capitalization	142	112	129	266	177	162
Market Cap Growth	32.10%	-13.03%	-51.73%	50.53%	9.59%	159.56%
Enterprise Value	119	75	84	272	164	153
Last Close Price	3.04	2.40	2.76	5.72	5.18	5.20
PS Ratio	46.82	16.33	13.05	14.39	87.04	18.64
PB Ratio	13.50	3.62	2.61	4.00	26.43	12.54
P/TBV Ratio	84.00	5.08	3.18	4.62	-	40.90
EV/Sales Ratio	39.33	11.02	8.49	14.68	80.41	17.60
Debt / Equity Ratio	0.01	0.01	0.12	0.24	1.59	0.02
Net Debt / Equity Ratio	-2.16	-0.95	-0.76	-0.98	0.67	-0.37
Net Debt / EBITDA Ratio	0.75	1.39	1.40	3.69	-0.18	0.26
Net Debt / FCF Ratio	0.71	0.97	1.09	6.92	-0.16	0.25
Asset Turnover	0.05	0.11	0.12	0.30	0.10	0.41
Inventory Turnover	0.03	0.16	0.43	1.76	9.66	23.96
Quick Ratio	3.48	4.42	2.31	2.96	0.51	0.98
Current Ratio	5.85	5.95	2.86	3.15	0.60	1.14
Return on Equity (ROE)	-112.95%	-48.33%	-35.09%	-53.73%	-267.02%	-125.93%
Return on Assets (ROA)	-32.31%	-20.82%	-20.14%	-18.70%	-78.14%	-56.00%
Return on Capital Employed (ROCE)	-65.80%	-41.40%	-54.50%	-25.20%	-380.20%	-147.00%
Earnings Yield	-18.41%	-17.33%	-15.82%	-7.39%	-14.77%	-11.37%
FCF Yield	-22.50%	-26.86%	-26.91%	-3.55%	-15.74%	-11.92%
Buyback Yield / Dilution	-2.26%	-0.02%	-25.14%	-14.56%	-8.72%	-5.98%

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.